Results 131 to 140 of about 2,566,443 (193)

Monitoring and Achievement of Target Serum Urate Among Gout Patients Receiving Long-Term Urate-Lowering Therapy in the American College of Rheumatology RISE Registry. [PDF]

Arthritis Care Res (Hoboken), 2023
Hammam N, Li J, Kay J, Izadi Z, Yazdany J, Schmajuk G.   +5 more
europepmc   +1 more source

Development of a patient decision aid for the initiation of urate-lowering therapy in gout patients. [PDF]

RMD Open, 2022
Te Kampe R, Boonen A, Jansen T, Janssen M, de Vries H, van Durme C.   +5 more
europepmc   +1 more source

Effects of Citrate Mixture on Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Underexcretion-Type Gout Patients: A Prospective Cohort Study. [PDF]

J Inflamm Res
Xu L, Cheng J, Cui L, Guo K, Wang C, Qi H, Zhang Q, He Y, Li X, Han L, Wang X, Sun W, Zhang X, Sun M, Li C, Liu Z.   +15 more
europepmc   +1 more source

Caring for Australians and New Zealanders With Kidney Impairment Guidelines: Rapid Development of Urate Lowering Therapy Guidelines for People With CKD. [PDF]

Kidney Int Rep, 2022
Stanley IK, Phoon RKS, Toussaint ND, Cullen V, Kearns J, Dalbeth N, Johnson DW, Krishnasamy R, Tunnicliffe DJ, CARI Guidelines Steering Committee.   +9 more
europepmc   +1 more source

Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink. [PDF]

Ann Rheum Dis, 2023
Roddy E, Bajpai R, Forrester H, Partington RJ, Mallen CD, Clarson LE, Padmanabhan N, Whittle R, Muller S.   +8 more
europepmc   +1 more source

Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial. [PDF]

Arthritis Care Res (Hoboken)
Barry A, England BR, Sayles H, Helget LN, Androsenko M, Wu H, Michaud K, Kramer B, Newcomb JA, Brophy MT, Davis-Karim A, Ferguson R, Pillinger MH, Neogi T, Palevsky PM, O'Dell JR, Mikuls TR.   +16 more
europepmc   +1 more source

Gout Remission With Pegloticase-Induced Intensive Urate-Lowering Therapy: A Post Hoc Clinical Trial Analysis. [PDF]

ACR Open Rheumatol
Klionsky Y, Torralba KD, Obermeyer K, Padnick-Silver L, Lam G, LaMoreaux B.   +5 more
europepmc   +1 more source

Correction to: Timing of urate-lowering therapy and risk of kidney failure and mortality in CKD: an application of the parametric G-formula. [PDF]

Clin Kidney J
europepmc   +1 more source

Outcomes in Patients With Multiple Myeloma and Prescribed Urate-Lowering Therapy: A Propensity-Matched Study. [PDF]

Cureus
Eidbo S, Barnett M, Lema Rodriguez D, Tsibadze N, Pappas A, Shah M, Shah A, Mayo R.   +7 more
europepmc   +1 more source

Combination of sodium-glucose cotransporter type 2 inhibitors and urate-lowering therapy in people with gout from a specialist clinic: a retrospective, single-center observational study. [PDF]

Front Med (Lausanne)
Doménech-Serrano J, García-Loiseau I, Rodríguez-Alvear C, Riesgo-Sanchis P, Moreno-Pérez Ó, Andrés M.   +5 more
europepmc   +1 more source